Page 3 - Management of Advanced Urothelial Carcinoma: Emerging Therapies and Biomarkers
P. 3
Presenter Disclosure
Scott North
Company / Organization Details
I am a member of an Advisory Board or equivalent with a Astellas National Advisory Board
commercial organization
I have received a grant(s) or an honorarium from a commercial Astellas, Sanofi, Janssen, Novartis, Merck, Honoraria
organization or non-commercial organization Roche, CUA
I am currently participating in or have participated in a clinical trial Roche, Merck, Astellas All funds paid to AHS
within the past two year